Would you recommend the following article to a politician, an athlete, a business executive, or a scientist?

Cytec pays \$1.85bn for UCB unit Cytec Industries Inc. is buying the chemicals division of Belgian drugs company UCB in a 1.5 billion euro (\$1.85 billion) cash and stock deal, the US specialty chemical firm said on Friday.
